Labcorp, Charles River and FDA Announce Research Collaboration to Advance Preclinical Methods for Evaluating Drug Abuse Potential
Labcorp announced a research collaboration with the FDA and Charles River Laboratories to advance preclinical methods for evaluating a medicine's abuse potential using harmonized behavioral economics methodology. Labcorp will contribute its regulatory abuse-potential study experience dating to 2009, while FDA scientists handle data analysis and regulatory science expertise.
Key figures
- Employees
- nearly 71,000
- Tests performed
- 750 million
- Countries served
- approximately 100
- Abuse potential experience since
- 2009
- Fda 2025 approvals supported pct
- 85%
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.